In the murky tale of Indian pharma giant Ranbaxy’s unfair business practices and its eventual culmination into a massive $500 million settlement in the US, one name stands out for fair play. If Preet Bharara was instrumental in dismantling the citadel of Rajat Gupta, Dinesh Thakur remains conspicuous for having the gall to relentlessly fight a company not only revered for producing affordable drugs, but one which also had the scale needed to blunt any attack on it.
Yet, little is known about Thakur, who followed his conscience and single-handedly pursued his goal to its logical end, resulting in one of the largest monetary settlements in the history of pharmaceutical companies anywhere in the world.
After taking a US engineering degree, Thakur worked with Bristol-Myers Squibb for over a decade before joining Ranbaxy in November 2002. He relocated from the US to the firm’s Gurgaon facility in June 2003, when Ranbaxy was brimming with energy and was one of India’s first multinationals.
Thakur managed Ranbaxy’s products portfolio...